# A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants.

> **NCT05858788** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 10 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** SAR441566

## Key facts

- **NCT ID:** NCT05858788
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-15
- **Primary completion:** 2023-07-17
- **Final completion:** 2023-07-17
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05858788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05858788, "A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05858788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*